Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein S2 pseudogene 44 (RPS2P44) is one of many processed pseudogenes in the human genome derived from the ribosomal protein S2 gene (RPS2)[5]. Pseudogenes like RPS2P44 are nonfunctional DNA sequences that resemble known genes but have accumulated disabling mutations or lack regulatory sequences required for expression. These sequences do not encode functional proteins and typically do not participate in biological pathways or disease processes. RPS2P44 is distinguished from the functional RPS2 gene, which encodes a critical component of the 40S subunit of the eukaryotic ribosome and is involved in cellular protein synthesis[1][3]. No evidence supports a direct pathological, pharmacological, or regulatory role for ribosomal protein S2 pseudogene 44 in humans. If you intended a functional ribosomal protein, the correct target is "40S ribosomal protein S2" (RPS2), not its pseudogene RPS2P44[1][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein S2 pseudogene 44 (RPS2P44).